Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 164

1.

A Location-Based Objective Assessment of Physical Activity and Sedentary Behavior in Ambulatory Hemodialysis Patients.

More KM, Blanchard C, Theou O, Cranston A, Vinson AJ, Dipchand C, Kiberd B, Tennankore KK.

Can J Kidney Health Dis. 2019 Aug 28;6:2054358119872967. doi: 10.1177/2054358119872967. eCollection 2019.

2.

Referral for Kidney Transplantation in Canadian Provinces.

Kim SJ, Gill JS, Knoll G, Campbell P, Cantarovich M, Cole E, Kiberd B.

J Am Soc Nephrol. 2019 Sep;30(9):1708-1721. doi: 10.1681/ASN.2019020127. Epub 2019 Aug 6.

PMID:
31387925
3.

A contemporary description of patients' estimated blood losses from diagnostic phlebotomy in a census of hospital episodes from a Canadian tertiary care center.

Quinn JG, Levy AR, Cheng CK, Doucette S, Theriault C, Doiron D, Kiberd BA, Tennankore KK.

Transfusion. 2019 Sep;59(9):2849-2856. doi: 10.1111/trf.15434. Epub 2019 Jul 8.

PMID:
31283032
4.

Optimizing Ambulance Transport of Hemodialysis Patients to the Emergency Department: A Cohort Study.

Vinson AJ, Bartolacci J, Goldstein J, Swain J, Clark D, Kiberd B, Tennankore KK.

Can J Kidney Health Dis. 2019 Jun 18;6:2054358119848127. doi: 10.1177/2054358119848127. eCollection 2019.

5.

Nonimmunologic Donor-Recipient Pairing, HLA Matching, and Graft Loss in Deceased Donor Kidney Transplantation.

Vinson AJ, Kiberd BA, Davis RB, Tennankore KK.

Transplant Direct. 2018 Dec 19;5(1):e414. doi: 10.1097/TXD.0000000000000856. eCollection 2019 Jan.

6.

Transplanting Hepatitis C Virus-Infected or Uninfected Kidneys Into Hepatitis C Virus-Infected Recipients.

Kiberd B, Doucette K, Vinson A, Tennankore K.

Ann Intern Med. 2018 Dec 18;169(12):897-898. doi: 10.7326/L18-0565. No abstract available.

PMID:
30557434
7.

Establishing a Core Outcome Measure for Life Participation: A Standardized Outcomes in Nephrology-kidney Transplantation Consensus Workshop Report.

Ju A, Josephson MA, Butt Z, Jowsey-Gregoire S, Tan J, Taylor Q, Fowler K, Dobbels F, Caskey F, Jha V, Locke J, Knoll G, Ahn C, Hanson CS, Sautenet B, Manera K, Craig JC, Howell M, Rutherford C, Tong A, Harden P, Hawley C, Holdaas H, Israni A, Jesse M, Kane B, Kanellis J, Kiberd B, Kim J, Larsen C, Leichtman A, Lentine K, Malone A, Mannon R, Oberbauer R, Patzer R, Peipert JD, Phan HA, Poggio E, Reed R, Scandling J, Tang I, Watson C, Contrares D, Contreras P, Cross D, Juodvalkis E, Koide D, Koide J, Kozarewicz A, Kozarewicz L, Kozarewicz R, Koritala A, Lisiecki E, Lipuma C, Lyman M, Mueller R, Mueller G, Noble L, Nolan N, Nolan S, Thomas J, Urbancyzk L, Zerante J, Zerante S; SONG-Tx Life Participation Workshop Investigators; Health professionals (*includes 2 patients from the SONG-Tx Graft Health Expert Working Group); Patients and family members.

Transplantation. 2019 Jun;103(6):1199-1205. doi: 10.1097/TP.0000000000002476.

PMID:
30300284
8.

The Use of Donation After Circulatory Death Organs for Simultaneous Liver-kidney Transplant: To DCD or Not to DCD?

Vinson AJ, Gala-Lopez B, Tennankore K, Kiberd B.

Transplantation. 2019 Jun;103(6):1159-1167. doi: 10.1097/TP.0000000000002434.

PMID:
30211825
9.

Effectiveness of a Web-Based eHealth Portal for Delivery of Care to Home Dialysis Patients: A Single-Arm Pilot Study.

Kiberd J, Khan U, Stockman C, Radhakrishnan A, Phillips M, Kiberd BA, West KA, Soroka S, Chan C, Tennankore KK.

Can J Kidney Health Dis. 2018 Sep 7;5:2054358118794415. doi: 10.1177/2054358118794415. eCollection 2018.

10.

Factors Associated With Prolonged Warm Ischemia Time Among Deceased Donor Kidney Transplant Recipients.

Vinson AJ, Rose C, Kiberd BA, Odutayo A, Kim SJ, Alwayn I, Tennankore KK.

Transplant Direct. 2018 Apr 18;4(5):e342. doi: 10.1097/TXD.0000000000000781. eCollection 2018 May.

11.

Hepatitis C virus-infected kidney waitlist patients: Treat now or treat later?

Kiberd BA, Doucette K, Vinson AJ, Tennankore KK.

Am J Transplant. 2018 Oct;18(10):2443-2450. doi: 10.1111/ajt.14891. Epub 2018 May 22.

12.

Burden of Emergency Medical Services Usage by Dialysis Patients.

Bartolacci J, Goldstein J, Kiberd B, Swain J, Vinson A, Clark D, Tennankore KK.

Prehosp Emerg Care. 2018 Nov-Dec;22(6):698-704. doi: 10.1080/10903127.2018.1454558. Epub 2018 Apr 19.

PMID:
29671664
13.

Lifetime risks of kidney donation: a medical decision analysis.

Kiberd BA, Tennankore KK.

BMJ Open. 2017 Sep 1;7(8):e016490. doi: 10.1136/bmjopen-2017-016490.

14.

Frailty in end-stage renal disease: comparing patient, caregiver, and clinician perspectives.

Clark DA, Khan U, Kiberd BA, Turner CC, Dixon A, Landry D, Moffatt HC, Moorhouse PA, Tennankore KK.

BMC Nephrol. 2017 May 2;18(1):148. doi: 10.1186/s12882-017-0558-x.

15.

Donor-Recipient Weight and Sex Mismatch and the Risk of Graft Loss in Renal Transplantation.

Miller AJ, Kiberd BA, Alwayn IP, Odutayo A, Tennankore KK.

Clin J Am Soc Nephrol. 2017 Apr 3;12(4):669-676. doi: 10.2215/CJN.07660716. Epub 2017 Mar 30.

16.

Targeting the Opioid Pathway for Uremic Pruritus: A Systematic Review and Meta-analysis.

Jaiswal D, Uzans D, Hayden J, Kiberd BA, Tennankore KK.

Can J Kidney Health Dis. 2016 Dec 13;3:2054358116675345. doi: 10.1177/2054358116675345. eCollection 2016.

17.

De Novo Donor-Specific Human Leukocyte Antigen Antibody Screening in Kidney Transplant Recipients After the First Year Posttransplantation: A Medical Decision Analysis.

Kiberd BA, Miller A, Martin S, Tennankore KK.

Am J Transplant. 2016 Nov;16(11):3212-3219. doi: 10.1111/ajt.13838. Epub 2016 May 23.

18.

The Authors Reply.

Tennankore KK, Kim SJ, Alwayn I, Kiberd BA.

Kidney Int. 2016 Jul;90(1):227. doi: 10.1016/j.kint.2016.03.017. No abstract available.

PMID:
27312454
19.

Prolonged warm ischemia time is associated with graft failure and mortality after kidney transplantation.

Tennankore KK, Kim SJ, Alwayn IP, Kiberd BA.

Kidney Int. 2016 Mar;89(3):648-58. doi: 10.1016/j.kint.2015.09.002. Epub 2015 Dec 30.

20.

Ramipril versus placebo in kidney transplant patients with proteinuria: a multicentre, double-blind, randomised controlled trial.

Knoll GA, Fergusson D, Chassé M, Hebert P, Wells G, Tibbles LA, Treleaven D, Holland D, White C, Muirhead N, Cantarovich M, Paquet M, Kiberd B, Gourishankar S, Shapiro J, Prasad R, Cole E, Pilmore H, Cronin V, Hogan D, Ramsay T, Gill J.

Lancet Diabetes Endocrinol. 2016 Apr;4(4):318-26. doi: 10.1016/S2213-8587(15)00368-X. Epub 2015 Oct 23.

PMID:
26608067
21.

Incidence, etiology, and significance of acute kidney injury in the early post-kidney transplant period.

Panek R, Tennankore KK, Kiberd BA.

Clin Transplant. 2016 Jan;30(1):66-70. doi: 10.1111/ctr.12660. Epub 2015 Nov 23.

PMID:
26497636
22.

Comorbidity burden at dialysis initiation and mortality: A cohort study.

Gomez AT, Kiberd BA, Royston JP, Alfaadhel T, Soroka SD, Hemmelgarn BR, Tennankore KK.

Can J Kidney Health Dis. 2015 Sep 8;2:34. doi: 10.1186/s40697-015-0068-3. eCollection 2015.

23.

A Survey of Increased Infectious Risk Donor Utilization in Canadian Transplant Programs.

Kumar D, Humar A, Kim SJ, Kiberd B.

Transplantation. 2016 Feb;100(2):461-4. doi: 10.1097/TP.0000000000000843.

PMID:
26285016
24.

Contraindications to kidney transplantation: uneven grounds?

Kiberd BA, AlBugami MM, Panek R, Tennankore K.

Transplant Res. 2015 Jul 21;4:2. doi: 10.1186/s13737-015-0024-x. eCollection 2015.

25.

Increases in intravenous magnesium use among hospitalized patients: an institution cross-sectional experience.

Kiberd BA, Tennankore KK, Daley CJ.

Can J Kidney Health Dis. 2015 Jun 13;2:24. doi: 10.1186/s40697-015-0056-7. eCollection 2015.

26.

Frailty and mortality in dialysis: evaluation of a clinical frailty scale.

Alfaadhel TA, Soroka SD, Kiberd BA, Landry D, Moorhouse P, Tennankore KK.

Clin J Am Soc Nephrol. 2015 May 7;10(5):832-40. doi: 10.2215/CJN.07760814. Epub 2015 Mar 4.

27.

Kidney donation and risk of ESRD.

Kiberd B, Tennankore K.

JAMA. 2014 Jul 2;312(1):93. doi: 10.1001/jama.2014.5518. No abstract available.

PMID:
25058225
28.

Cost-effectiveness of routine nucleic acid testing in organ donors.

Kiberd B.

Am J Transplant. 2014 Apr;14(4):979-80. doi: 10.1111/ajt.12638. Epub 2014 Feb 12. No abstract available.

29.

Malignancies: pre and post transplantation strategies.

AlBugami M, Kiberd B.

Transplant Rev (Orlando). 2014 Apr;28(2):76-83. doi: 10.1016/j.trre.2013.12.002. Epub 2013 Dec 13. Review.

PMID:
24439783
30.

Eligibility for the kidney transplant wait list: a model for conceptualizing patient risk.

Kiberd BA, Tennankore KK, West K.

Transplant Res. 2014 Jan 8;3(1):2. doi: 10.1186/2047-1440-3-2.

31.

Predicting 5-year risk of kidney transplant failure: a prediction instrument using data available at 1 year posttransplantation.

Shabir S, Halimi JM, Cherukuri A, Ball S, Ferro C, Lipkin G, Benavente D, Gatault P, Baker R, Kiberd B, Borrows R.

Am J Kidney Dis. 2014 Apr;63(4):643-51. doi: 10.1053/j.ajkd.2013.10.059. Epub 2013 Dec 31.

PMID:
24387794
32.

Screening for BK viremia.

AlBugami MM, Kiberd BA.

Transplantation. 2013 Oct 15;96(7):e50. doi: 10.1097/TP.0b013e3182a049e7. No abstract available.

PMID:
24100843
33.

Death, taxes, and now CKD.

Kiberd BA.

Am J Kidney Dis. 2013 Aug;62(2):220-2. doi: 10.1053/j.ajkd.2013.05.002. No abstract available.

PMID:
23883658
34.

The impact of vascular anastomosis time on early kidney transplant outcomes.

Marzouk K, Lawen J, Alwayn I, Kiberd BA.

Transplant Res. 2013 May 15;2(1):8. doi: 10.1186/2047-1440-2-8.

35.

Blood transfusion in deceased donor kidney transplantation.

Marzouk K, Lawen J, Kiberd BA.

Transplant Res. 2013 Apr 5;2(1):4. doi: 10.1186/2047-1440-2-4.

36.

Estimating the long term impact of kidney donation on life expectancy and end stage renal disease.

Kiberd BA.

Transplant Res. 2013 Feb 16;2(1):2. doi: 10.1186/2047-1440-2-2.

37.

Access to kidney transplantation: outcomes of the non-referred.

Albugami MM, Panek R, Soroka S, Tennankore K, Kiberd BA.

Transplant Res. 2012 Dec 10;1(1):22. doi: 10.1186/2047-1440-1-22.

38.

Colorectal cancer screening in kidney disease patients: working backwards.

Kiberd B.

Nephrol Dial Transplant. 2013 Apr;28(4):774-7. doi: 10.1093/ndt/gfs523. Epub 2012 Nov 4. No abstract available.

PMID:
23129825
39.

Limits to intensified mycophenolate mofetil dosing in kidney transplantation.

Kiberd BA, Lawen J, Daley C.

Ther Drug Monit. 2012 Dec;34(6):736-8. doi: 10.1097/FTD.0b013e31826d7bfa.

PMID:
23007746
40.

The impact of an "acute dialysis start" on the mortality attributed to the use of central venous catheters: a retrospective cohort study.

Tennankore KK, Soroka SD, Kiberd BA.

BMC Nephrol. 2012 Jul 30;13:72. doi: 10.1186/1471-2369-13-72.

41.

Kidney transplant survival in pediatric and young adults.

Kiberd JA, Acott P, Kiberd BA.

BMC Nephrol. 2011 Oct 7;12:54. doi: 10.1186/1471-2369-12-54.

42.

Macrocytosis may be associated with mortality in chronic hemodialysis patients: a prospective study.

Tennankore KK, Soroka SD, West KA, Kiberd BA.

BMC Nephrol. 2011 May 11;12:19. doi: 10.1186/1471-2369-12-19.

43.

Therapeutic drug monitoring of mycophenolates in kidney transplantation: report of The Transplantation Society consensus meeting.

Le Meur Y, Borrows R, Pescovitz MD, Budde K, Grinyo J, Bloom R, Gaston R, Walker RG, Kuypers D, van Gelder T, Kiberd B.

Transplant Rev (Orlando). 2011 Apr;25(2):58-64. doi: 10.1016/j.trre.2011.01.002. Epub 2011 Mar 30. No abstract available.

PMID:
21454067
44.

Simultaneous liver kidney transplantation: a medical decision analysis.

Kiberd B, Skedgel C, Alwayn I, Peltekian K.

Transplantation. 2011 Jan 15;91(1):121-7.

PMID:
21452416
45.

The role of proton pump inhibitors on early mycophenolic acid exposure in kidney transplantation: evidence from the CLEAR study.

Kiberd BA, Wrobel M, Dandavino R, Keown P, Gourishankar S.

Ther Drug Monit. 2011 Feb;33(1):120-3. doi: 10.1097/FTD.0b013e318206a1b1.

PMID:
21192310
46.

Screening for chronic kidney disease.

Kiberd B.

BMJ. 2010 Nov 8;341:c5734. doi: 10.1136/bmj.c5734. No abstract available.

PMID:
21059725
47.

Screening for proteinuria in kidney transplant recipients.

Panek R, Lawen T, Kiberd BA.

Nephrol Dial Transplant. 2011 Apr;26(4):1385-7. doi: 10.1093/ndt/gfq503. Epub 2010 Aug 16.

PMID:
20713978
48.

The CLEAR study: a 5-day, 3-g loading dose of mycophenolate mofetil versus standard 2-g dosing in renal transplantation.

Gourishankar S, Houde I, Keown PA, Landsberg D, Cardella CJ, Barama AA, Dandavino R, Shoker A, Pirc L, Wrobel MM, Kiberd BA.

Clin J Am Soc Nephrol. 2010 Jul;5(7):1282-9. doi: 10.2215/CJN.09091209. Epub 2010 May 24.

49.

Nephrology consults increase.

Kiberd BA, Soroka SD.

Kidney Int. 2010 Apr;77(7):645. doi: 10.1038/ki.2009.526. No abstract available.

50.

Nucleic acid testing (NAT) of organ donors: is the 'best' test the right test? A consensus conference report.

Humar A, Morris M, Blumberg E, Freeman R, Preiksaitis J, Kiberd B, Schweitzer E, Ganz S, Caliendo A, Orlowski JP, Wilson B, Kotton C, Michaels M, Kleinman S, Geier S, Murphy B, Green M, Levi M, Knoll G, Segev D, Brubaker S, Hasz R, Lebovitz DJ, Mulligan D, O'Connor K, Pruett T, Mozes M, Lee I, Delmonico F, Fischer S.

Am J Transplant. 2010 Apr;10(4):889-99. doi: 10.1111/j.1600-6143.2009.02992.x. Epub 2010 Jan 29. Review.

Supplemental Content

Loading ...
Support Center